Cite Filings / OTLK / 0001104659-25-010946
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

Outlook Therapeutics, Inc. · Filed 2025-02-10 · Acc 0001104659-25-010946

Documents 1

  • DEF 14A Proxy Statement , tm252313d6_def14a.htm

Around this filing

  • 2026-01-26 DEF 14A Proxy Statement
  • 2025-02-14 10-Q Quarterly Report
  • 2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-10 ARS Annual Report to Security Holders
  • 2025-02-10 DEF 14A Proxy Statement
  • 2025-02-06 4 Options or other derivatives
  • 2024-06-26 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading tm252313d6_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…